TABLE 3.
Cancer CNS nurses (n = 32) July 2019 | CPD Cohort 1 (n = 30) Oct. 2020 | CPD Cohort 2 (n = 41) Sept. 2021 | CPD Cohort 3 (n = 51) Sept. 2022 | |
---|---|---|---|---|
Specialist Nurse in Cancer Services | 32 | 8 | 9 | 25 |
Specialist Nurse in Cardiac Services | — | 6 | 7 | 6 |
Specialist Nurse in Immunology Services | — | 1 | — | — |
Diabetes Specialist Nurse | — | 1 | 1 | — |
FH Clinical Nurse Specialist | — | — | — | 1 |
Haematology Nurse | — | 4 | 2 | 4 |
Mitochondrial disease Specialist Nurse | — | 1 | — | — |
Urology/Renal Clinical Nurse Specialist | — | 1 | 1 | 1 |
Specialist Nurse in Neurological Services | — | 3 | 2 | — |
Midwives | — | 2 | 2 | — |
Paediatric Genomic Nurse Specialist | — | — | — | 3 |
Research Nurse | — | 2 | 6 | 1 |
Staff Nurse | — | — | 5 | — |
Associate Nurse | — | — | — | 1 |
Macmillan Cancer Navigator/Information Specialist | — | 1 | 1 | 3 |
Macmillan Professional Development Lead | — | — | — | 1 |
Senior/Lead Nurse involved in GMSAs | — | — | 7 | 5 |
Regional distribution | Southwest of England | All parts of England and three from Scotland | All seven GMSAs in England | All seven GMSAs in England |
Education or training received in genetics or genomics | 30% | 45% | 49% | 52% |